CXC chemokine receptor-2 ligands are necessary components of neutrophil- mediated host defense in invasive pulmonary aspergillosis

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6086-6094

  Mehrad, Borna ^a   Strieter, Robert M ^a   Moore, Thomas A ^a   Tsai, Wan C ^a   Lira, Sergio A ^b   Standiford, Theodore J ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 2;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HOST RESISTANCE; IMMUNE DEFICIENCY; LIGAND BINDING; LUNG ASPERGILLOSIS; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ASPERGILLOSIS; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; FEMALE; GROWTH SUBSTANCES; IMMUNOSUPPRESSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED C57BL; MONOKINES; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-8B;

EID: 0033485741     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Fraser, D. W., J. I. Ward, L. Ajello, and B. D. Plikaytis. 1979. Aspergillosis and other systemic mycoses: the growing problem J. Am. Med. Assoc. 242:1631.
2. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23.
3. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781.
4. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12:1147.
5. Walsh, T. J., J. W. Heimenz, N. L. Seibel, J. R. Perfect, G. Horwith, L. Lee, J. L. Sibler, M. J. DiNubile, A. Reboli, E. Bow, J. Lister, and E. J. Anaissie. 1998. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26:1383.
6. Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23:608.
7. Rankin, N. E. 1953. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br. Med. J. 183:918.
8. Khoo, S. H., and D. W. Denning. 1994. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19(Suppl 1):S41.
9. Wald, A., W. Leisenring, J. A. van Burik, and R. A. Bowden. 1997. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175:1459.
10. Cohen, M. S., R. E. Isturiz, H. L. Malech, R. K. Root, C. M. Wilfert, L. Gutman, and R. H. Buckley. 1981. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am. J. Med. 71:59.
11. Gerson, S. L., G. H. Talbot, S. Hurwitz, B. L. Strom, E. J. Lusk, and P. A. Cassileth. 1984. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann. Int. Med. 100:345.
12. Schaffner, A., H. Douglas, and A. Brande. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617.
13. Levitz, S. M., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483.
14. Rex, J. H., J. E. Bennett, J. I. Gallin, H. L. Malech, and D. A. Melnick. 1990. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J. Infect Dis. 162:523.
15. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and γ interferon. Infect Immun. 61:4870.
16. Morgenstern, D.E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185:207.
17. Cenci, E., A. Mencacci, C. Fe d'Ostiani, G. Del Sero, P. Mosci, C. Montagnoli, A. Bacci, and L. Romani. 1998. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J. Infect. Dis. 178:1750.
18. Smith, J. B., L. E. Rovai, and H. R. Herschman. 1997. Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines. J. Leukocyte Biol. 62:598.
19. Rovai, L. E., H. R. Herschman, and J. B. Smith. 1998. The murine neutrophilchemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J. Leukocyte Biol. 64:494.
20. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045.
21. Richardson, M. D., and M. Patel. 1995. Stimulation of neutrophil phagocytosis of Aspergillus fumigatus conidia by interleukin-8 and N-formylmethionyl-leucylphenylalanine. J. Med. Vet. Mycol. 33:99.
22. Thelen, M., P. Peveri, P. Kernen, V. von Tschamer, A. Walz, and M. Baggiolini. 1988. Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J. 2:2702.
23. Wolpe, S. D., G. Davatelis, B. Sherry, B. Beutler, D. G. Hesse, H. T. Nguyen, L. L. Moldawer, C. F. Nathan, S. F. Lowry, and A. Cerami. 1988. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167:570.
24. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3:2565.
25. Broaddus, V. C., A. M. Boylan, J. M. Hoeffel, K. J. Kim, M. Sadick, A. Chuntharapai, and C. A. Hebert. 1994. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunol. 152:2960.
26. Sekido, N., N. Mukaida, A. Harada, I. Nakanishi, Y. Watanabe, and K. Matsushima. 1993. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365:654.
27. Xing, Z., M. Jordana, H. Kirpalani, K. E. Driscoll, T. J. Schall, and J. Gauldie. 1994. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-α, macrophage inflammatory protein-2, interleukin-1β, and interleukin-6 but not RANTES or transforming growth factor-β1 mRNA expression in acute lung inflammation. [Published erratum appears in 1994, Am. J. Respir. Cell. Mol. Biol. 10:346]. Am. J. Respir. Cell. Mol. Biol. 10:148.
28. Huang, S., J. D. Paulauskis, J. J. Godleski, and L. Kobzik. 1992. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am. J. Pathol. 141:981.
29. Greenberger, M. J., R. M. Stricter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996 Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumomiae. J. Infect. Dis. 173:159.
30. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1994. Both interleukin-8 receptors independently mediate chemotaxis: Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO a and NAP-2. FEBS Lett. 341:187.
31. Morohashi, H., T. Miyawaki, H. Nomura, K. Kuno, S. Murakami, K. Matsushima, and N. Mukaida. 1995. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J. Leukocyte Biol, 57:180.
32. Thomas, K. M., L. Taylor, and J. Navarro. 1991. The interleukin-8 receptor is encoded by a neutrophil-specific CDNA clone, F3R. J. Biol. Chem. 266:14839.
33. Moser, B., C. Schumacher, V. von Tschamer, I. Clark-Lewis, and M. Baggiolini. 1991. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J. Biol. Chem. 266:10666.
34. Ahuja, S. K., and P. M. Murphy. 1996. The CXC chemokines growth-regulated oncogene (GRO) alpha α, GROβ GROγ, neutrophil-activaling peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271: 20545.
35. Lee, J., G. Cacalano, T. Camerato, K. Toy, M. W. Moore, and W. I. Wood. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155:2158.
36. Terkeltaub, R., S. Baird, P. Sears, R. Santiago, and W. Boisvert. 1998. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis. Arthritis Rheum. 41:900.
37. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Stricter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-I). Immunol. Invest. 21:39.
38. Strieter, R. M., S. L. Kunkel, M. D. Burdick, P. M. Lincoln, and A. Walz. 1992. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21:589.
39. Hebert, C. A., A. Chuntharapai, M. Smith, T. Colby, J. Kim, and R. Horuk. 1993. Partial functional mapping of the human interleukin-8 type A receptor: identification of a major ligand binding domain. J. Biol. Chem. 268:18549.
40. Lira, S. A., P. Zalamea, S. N. Heinrich, M. E. Fuentes, D. Carrasco, A. C. Lewin, D. S. Barton, S. Durham, and R. Bravo. 1994. Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J. Exp. Med. 180:2039.
41. Lira, S. A., M. E. Fuentes, R. M. Strieter, and S. K. Durham. 1997. Transgenic methods to study chemokine function in lung and central nervous system. Methods Enzymol. 287:304.
42. Lira, S. A. 1996. Genetic approaches to study chemokine function. J. Leukocyte Biol. 59:45.
43. Fleming, T. J., M. L. Fleming, and T. R. Malek. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow: RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:2399.
44. Lai, L., N. Alveradi, L. Maltais, and H. C. Morse III. 1998. Mouse cell surface antigens: nomenclature and immunophenotyping. J. Immunol. 160:3861.
45. Lewinsohn, D. M., R. F. Bargatze, and E. C. Butcher. 1987. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J. Immunol. 138:4313.
46. Pennline, K. J., F. Pellerilo, M. DaFonseca, P. Monahan, M. I. Siegel, and S. R. Smith. 1990. Flow cytometric analysis of recombinant murine GM-CSF (rmuGM-CSF) induced changes in the distribution of specific cell populations in vivo. Cytometry 11:283.
47. Tepper, R. I., R. L. Coffman, and P. Leder. 1992. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548.
48. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffit. 1994. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001.
49. Lehmann, P. F., and L. O. White. 197S. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigalus mycelium in mice. Infect. Immun. 12:987.
50. Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978.
51. Greenberger, M. J., R. M. Stricter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumoniae. J. Immunol. 155:722.
52. Shahan, T. A., W. G. Sorenson, J. D. Paulauskis, R. Morey, and D. M. Lewis. 1998. Concentration- and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1α in rat alveolar macrophages by fungal spores implicated in airway inflammation. Am. J. Respir. Cell. Mol. Biol. 18:435.
53. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
54. Mehrad, B., R. M. Stricter, and T. J. Standiford 1999. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 162:1633.
55. Yoshimura, T., and D. G. Johnson. 1993. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1): NAP-1 is highly conserved in guinea pig. J. Immunol. 151:6225.
56. Tekamp-Olson, P., C. Gallegos, D. Bauer, J. McClain, B. Sherry, M. Fabre, S. van Deventer, and A. Cerami. 1990. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J. Exp. Med. 172:911.
57. Kooguchi, K., S. Hashimoto, A. Kobayashi, Y. Kitamura, I. Kudoh, J. Wiener-Kronish, and T. Sawa. 1998. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66:3164.
58. Tsai, W. C., R. M. Stricter, J. M. Wilkowski, K. A. Bucknell, M. D. Burdick, S. A. Lira, and T. J. Sundiford. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161:2435.
59. Wuyts, A., A. Haelens, P. Proost, J. P. Lenaerts, R. Conings, G. Opdenakker, and J. Van Danune. 1996. Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells: functional comparison with natural KC and macrophage SA inflammatory protein-2. J. Immunol. 157:1736.